Recursion Pharmaceuticals, Inc. RXRX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s total current assets?
- Recursion Pharmaceuticals, Inc. (RXRX) reported total current assets of $709.56M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s total current assets changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s total current assets increased by 21.5% year-over-year, from $584.15M to $709.56M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s total current assets has grown at a 25.0% compound annual growth rate (CAGR), from $266.44M to $812.85M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.